📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
Fairchem Organics Q3 FY26 Revenue Drops 12% to ₹100 Cr; EBITDA Margins Squeeze to 4.2%
Fairchem Organics reported a weak Q3 FY26 with revenue declining 12% YoY to ₹100 crores and EBITDA falling to ₹4 crores due to lower demand from the paint sector and Chinese dumping. Profitability was severely impacted by a duty inversion where raw materials face 16.5% duty while finished products face only 7.5%. Management expects a gradual recovery starting H2 FY27, supported by new trade agreements with the US and EU and the launch of an animal feed plant. The company is also working on cost-saving measures and domestic catalyst replacement to improve margins.
Key Highlights
Q3 Revenue stood at ₹100 crores, a 12% YoY decline, while 9M FY26 revenue fell 18% to ₹343 crores.
EBITDA margins compressed to 4.2% in Q3 and 3.97% for 9M FY26, impacted by elevated raw material costs.
Adjusted PAT for the quarter was ₹60 lakhs (0.6% margin) after an ₹88 lakh exceptional item for labor code implementation.
Management highlighted a duty disadvantage with raw material duties at 16.5% versus 7.5% for imported dimer acid.
Animal feed plant is ready and awaiting GMP certification, with a new value-added product slated for Q3 FY27.
💼 Action for Investors
Investors should remain cautious as the company faces significant margin pressure from Chinese imports and high raw material duties. Monitor the recovery in export volumes to the US and the commissioning of the animal feed plant in the coming quarters for signs of a turnaround.
Fairchem Organics Q3 FY26 PAT Plummets 83% YoY to INR 6 Mn Amid Margin Pressure
Fairchem Organics reported a weak performance for Q3 FY26, with revenue declining 12% YoY to INR 1,001 Mn and PAT (excluding exceptional items) dropping 83% to INR 6 Mn. EBITDA margins contracted significantly to 4.20% from 6.87% a year ago, driven by elevated raw material costs and aggressive pricing from Chinese competitors. The company faced headwinds in the domestic paint segment due to a new market entrant and a temporary halt in US exports. Management expects a recovery in high-margin exports following recent tariff adjustments in the US and potential FTAs with the UK and EU.
Key Highlights
Q3 FY26 Revenue fell 11.9% YoY to INR 1,001 Mn, while 9M FY26 revenue dropped 17.8% to INR 3,427 Mn.
EBITDA for Q3 FY26 declined by 46.2% YoY to INR 42 Mn, with margins shrinking by 267 bps to 4.20%.
PAT (excluding exceptional items) saw a sharp decline of 82.9% YoY, reaching only INR 6 Mn for the quarter.
Raw material costs remained high due to a 16.5% custom duty compared to the original 5.5%, impacting Dimer Acid margins.
Successfully concluded a buyback of INR 340 Mn in January 2026, increasing promoter holding to 63.25%.
💼 Action for Investors
Investors should exercise caution as the company faces intense margin pressure from high input costs and Chinese competition. Monitor the ramp-up of exports to the US and Europe as the primary catalyst for a potential recovery in profitability.
Fairchem Organics Reports Q3 FY26 Net Loss of ₹9.71 Lakhs; Revenue Down 11.8% YoY
Fairchem Organics reported a weak performance for the quarter ended December 31, 2025, with revenue from operations declining 11.8% YoY to ₹10,013.40 Lakhs. The company swung to a net loss of ₹9.71 Lakhs from a profit of ₹351.78 Lakhs in the previous year's corresponding quarter. Performance was impacted by an exceptional charge of ₹88.27 Lakhs related to new labor code regulations and overall margin compression. For the nine-month period, net profit plummeted by over 91% YoY to ₹184.87 Lakhs.
Key Highlights
Revenue from operations decreased to ₹10,013.40 Lakhs in Q3 FY26 from ₹11,357.08 Lakhs in Q3 FY25.
Reported a net loss of ₹9.71 Lakhs for the quarter compared to a profit of ₹351.78 Lakhs YoY.
Nine-month PAT (9M FY26) stood at ₹184.87 Lakhs, a 91.3% decline from ₹2,138.06 Lakhs in 9M FY25.
Recognized an exceptional expense of ₹88.27 Lakhs due to the implementation of the Code on Wages, 2019.
Completed a buyback of 4,25,000 equity shares at ₹800 per share for a total of ₹34 Crores in January 2026.
💼 Action for Investors
The significant drop in profitability and revenue suggests severe margin pressure in the specialty chemicals segment. Investors should remain cautious and monitor the company's ability to pass on costs and improve operational efficiency in upcoming quarters.
Fairchem Organics Reports Q3 FY26 Net Loss of ₹9.71 Lakhs; Revenue Down 11.8% YoY
Fairchem Organics Limited reported a challenging Q3 FY26, with revenue from operations declining to ₹10,013.40 Lakhs from ₹11,357.08 Lakhs YoY. The company swung to a net loss of ₹9.71 Lakhs for the quarter, significantly impacted by an exceptional item of ₹88.27 Lakhs related to new labor code regulations. For the nine-month period ending December 2025, net profit plummeted to ₹184.87 Lakhs compared to ₹2,138.06 Lakhs in the previous year. Despite the weak earnings, the company successfully completed a ₹34 Crore share buyback at ₹800 per share in January 2026.
Key Highlights
Revenue from operations decreased by 11.8% YoY to ₹10,013.40 Lakhs in Q3 FY26.
Reported a Net Loss of ₹9.71 Lakhs in Q3 FY26 versus a Net Profit of ₹351.78 Lakhs in Q3 FY25.
Exceptional charge of ₹88.27 Lakhs recognized for employee benefit obligations under new Labour Codes.
Completed buyback of 4,25,000 shares at ₹800 each, totaling ₹34 Crores, with shares extinguished on Jan 27, 2026.
Nine-month revenue stood at ₹34,271.98 Lakhs, down from ₹41,711.77 Lakhs in the prior year period.
💼 Action for Investors
The sharp decline in profitability and revenue suggests significant operational headwinds in the specialty chemicals sector. Investors should remain cautious and monitor for margin stabilization, as the recent buyback at ₹800 provides a psychological floor but does not offset the weak earnings performance.
Fairchem Organics Completes Extinguishment of 4.25 Lakh Equity Shares Post-Buyback
Fairchem Organics has successfully completed the extinguishment of 4,25,000 equity shares following its recent buyback program. This action has reduced the company's total paid-up share capital from 1,30,20,902 shares to 1,25,95,902 shares, representing a reduction of approximately 3.26%. The extinguishment was finalized on January 27, 2026, in compliance with SEBI Buy-Back Regulations. Such a reduction in the share base typically leads to an improvement in Earnings Per Share (EPS) and Return on Equity (ROE) for existing shareholders.
Key Highlights
Extinguished 4,25,000 equity shares of face value Rs. 10 each on January 27, 2026
Total paid-up share capital reduced from INR 13.02 crore to INR 12.60 crore
Total outstanding equity shares decreased from 1,30,20,902 to 1,25,95,902
The buyback tendering period was conducted between January 8 and January 14, 2026
The extinguishment was confirmed by CDSL and verified by secretarial auditors
💼 Action for Investors
The reduction in equity base is a positive development that enhances shareholder value through improved financial ratios. Investors should hold their positions as the lower share count will marginally boost future EPS.
Fairchem Organics Completes Buyback of 76,045 Equity Shares at ₹1,315 Per Share
Fairchem Organics Limited has successfully concluded its share buyback program through the tender offer route. The company repurchased 76,045 equity shares at a price of ₹1,315 per share, involving a total capital outlay of ₹10 crore. This buyback has resulted in a reduction of the total paid-up equity capital, which may lead to a marginal improvement in Earnings Per Share (EPS) for remaining shareholders.
Key Highlights
Repurchased 76,045 equity shares at a premium price of ₹1,315 per share.
Total buyback size amounted to ₹10 crore, excluding transaction costs and taxes.
The buyback was conducted via the Tender Offer route as per SEBI regulations.
Post-buyback, the total number of equity shares has been reduced, potentially enhancing return ratios.
💼 Action for Investors
As the buyback is now complete and shares have been extinguished, investors should focus on the company's operational performance and the resulting impact on EPS in the next quarterly report.
Fairchem Organics Announces Buyback of 4.25 Lakh Shares at ₹800 Per Share via Tender Offer
Fairchem Organics Limited has issued a Letter of Offer for the buyback of up to 4,25,000 equity shares at a price of ₹800 per share, totaling ₹3,400 lakhs. The buyback represents 3.26% of the total equity and 16% of the company's paid-up capital and free reserves as of March 2025. The process will be conducted via the tender offer route, with the acceptance window open from January 8 to January 14, 2026. The record date for determining eligibility was January 5, 2026.
Key Highlights
Buyback of 4,25,000 shares at a fixed price of ₹800 per share via tender route
Total buyback size of ₹3,400 lakhs represents 16% of the company's net worth
Small shareholder entitlement ratio is approximately 29 shares for every 488 shares held
General category entitlement ratio is approximately 55 shares for every 606 shares held
Tendering period scheduled from January 8, 2026, to January 14, 2026
💼 Action for Investors
Eligible shareholders should evaluate the premium of the ₹800 buyback price over the current market price and consider tendering their shares before the January 14 deadline.
Fairchem Organics Shareholders Approve ₹34 Crore Buyback at ₹800 Per Share
Fairchem Organics Limited has received shareholder approval via postal ballot for a buyback of up to 4,25,000 equity shares. The buyback is priced at ₹800 per share, representing a premium of approximately 14.77% over the closing price on the date of the board's initial approval. The total buyback size is capped at ₹3,400 lakhs, which accounts for 16% of the company's total paid-up equity capital and free reserves. The process will be conducted through the tender offer route, providing an opportunity for shareholders to exit at a premium.
Key Highlights
Buyback of up to 4,25,000 fully paid-up equity shares at ₹800 per share
Total buyback size capped at ₹3,400 lakhs, representing 16% of aggregate paid-up capital and free reserves
Buyback to be executed through the 'Tender Offer' route on a proportionate basis
15% reservation of the buyback size (63,750 shares) for small shareholders as per SEBI regulations
The buyback price represents a premium of ~14.16% and ~14.77% over BSE and NSE closing prices as of Nov 20, 2025
💼 Action for Investors
Investors should watch for the announcement of the Record Date to determine eligibility for participation in the tender offer. Small shareholders may find this particularly attractive due to the 15% reservation and the premium over current market prices.
Fairchem Organics Sets Jan 5, 2026 as Record Date for Rs 34 Cr Buyback at Rs 800/Share
Fairchem Organics Limited has officially fixed January 5, 2026, as the record date for its upcoming share buyback. The company intends to repurchase up to 4,25,000 equity shares at a price of Rs 800 per share, which is a significant premium to recent trading prices. The total buyback size is capped at Rs 34 crore and will be executed through the tender offer route. Shareholders must hold the shares in their demat accounts by the record date to be eligible for participation.
Key Highlights
Buyback of up to 4,25,000 equity shares at a fixed price of Rs 800 per share
Total aggregate amount for the buyback is INR 3,400 lakhs (Rs 34 crore)
Record date for determining eligibility is fixed as Monday, January 5, 2026
The process will be conducted via a proportionate tender offer as per SEBI regulations
Shareholder approval for the buyback was previously obtained on December 26, 2025
💼 Action for Investors
Investors looking to benefit from the buyback premium should ensure they own the shares before the ex-date to be eligible by the January 5 record date. Evaluate the buyback price against the current market price to determine the potential gains from tendering shares.
Fairchem Organics Shareholders Approve Equity Share Buyback with 99.99% Majority
Fairchem Organics Limited has received overwhelming shareholder approval for its proposed equity share buyback via the tender offer route. The postal ballot results showed that 99.99% of the votes cast, totaling 8,552,615 shares, were in favor of the special resolution. The voting process concluded on December 26, 2025, following a month-long e-voting period. This approval allows the company to proceed with the buyback, which is typically viewed as a positive signal regarding management's confidence in the company's valuation.
Key Highlights
Special resolution for buyback of equity shares passed with 99.99% majority support.
A total of 8,552,615 votes were cast in favor, while only 1,034 votes (0.01%) were against.
The buyback will be conducted through the tender offer route as per SEBI regulations.
The voting period for the postal ballot ran from November 26 to December 26, 2025.
💼 Action for Investors
Investors should monitor upcoming disclosures for the specific buyback price and record date to evaluate the potential premium. This move suggests a healthy cash position and a commitment to returning value to shareholders.